Trulieve Cannabis Corp.

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers on September 17, 1940 and is headquartered in Tallahassee, FL.

TALLAHASSEE, Fla. , Sept. 7, 2023 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced planned event participation in September.

Trulieve Announces September 2023 Event Participation

Marijuana stocks could be the investment you need to make. To begin the cannabis industry is still young. Often times in an emerging industry there are a fair amount of obstacles to overcome. But there are also moments where investment opportunities take place. The cannabis sector is one that has a large amount of volatility. What this means is that a company can either trade up or down without warning. But for most marijuana stocks there has been a downtrend due to the amount of volatile behavior.

3 Marijuana Stocks For Cannabis Investing September 2023

Aurora Cannabis

Canopy Growth

Cronos Group

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

OrganiGram Holdings Inc.

Tilray Brands

Cannabis stocks continued to move higher following the Labor Day long weekend after the U.S. Department of Health and Human Services (HHS) last week recommended reclassifying marijuana as a lower-risk drug.

Cannabis stock rally continues on marijuana rescheduling hopes

2 Marijuana Stocks To Watch In September 2023

Cannabis stocks are on track to finish the week higher boosted by the news that the U.S. Department of Health and Human Services (HHS) has recommended reclassifying marijuana as a lower-risk drug.

Cannabis stocks set to end week on a high following marijuana rescheduling recommendation

Trulieve Cannabis stock soared 62% following the potential rescheduling of cannabis from a Schedule 1 controlled substance to a Schedule 3 drug. If cannabis is reclassified, Trulieve and other MSOs could potentially drop the 280E taxes and uplist to U.S. stock exchanges. Trulieve Cannabis could see a surge in free cash flow levels, greatly enhancing its capital position.

Trulieve Cannabis: Government May Finally Come To The Rescue

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

The move by the Drug Enforcement Administration to review the Schedule I classification for cannabis sparked a wave of speculation and mostly positive comments from Wall Street on Thursday, but many questions remain.

HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain

The US government is reconsidering how it classifies marijuana and cannabis companies are in party mode. According to reports, the Department of Health and Human Services (HHS) has recommended reclassifying marijuana as a lower-risk Schedule III drug, from Schedule I, easing restrictions on businesses operating in the sector.

Cannabis stocks on fire as US health department calls for easing restrictions

The U.S. Department of Health and Human Services is recommending to the U.S. Drug Enforcement Administration that cannabis should be reclassified as a Schedule III controlled substance under U.S. law from Schedule I now, according to a report by Bloomberg. Cannabis stocks are rallying, with the AdviserShares Pure US Cannabis ETF MSOS, +18.76% up by nearly 33%, and the ETFMG Alternative Harvest ETF MJ, +10.27% up by 19.5%.

U.S. Dept. of Health and Human Services recommends re-scheduling cannabis, as stocks in the sector rally

As the cannabis sector in the United States continues to expand, three notable marijuana stocks have emerged, with potential gains this week. The US cannabis industry seems promising, with a compound annual growth rate of 18.1% from 2021 to 2028. Curaleaf Holdings provides erratic but potentially profitable choices for short-term traders. Long-term investors, on the other hand, may find value in creative companies like Green Thumb Industries and their planned expansion plans.

High-Potential US Marijuana Stocks for Your Radar Ahead of September 2023

High Tide

Jazz Pharmaceuticals

SNDL Inc.

I will attempt to assess and rank the relative growth potential of the separate competitors in the industry. The industry faces multiple catalysts and is trading near 52-week lows. The cannabis ETFs are full of cash burning companies, so I am forced to research my own basket of stocks.

Finding The Long-Term Winners In The Cannabis Sector, August 2023 Update

Kinross Gold

Polestar Automotive Holding UK PLC

The massive euphoria in penny stocks has not repeated since 2021. The reason is tight monetary policies that have dampened overall market sentiments.

Penny Stock Goldmines: 3 Gems to Grab for Massive Gains by 2024

In Q3 2023, US marijuana stocks emerged as important stock market players, reflecting the fast-growing cannabis sector. The US cannabis sector has attracted attention for its profitable potential, with an astounding annual growth rate of 30% in 2023. In general, the future of the cannabis sector in the United States remains bright, thanks to rising legalization and altering societal attitudes.

Top US Marijuana Stocks to Watch in Q3 2023: Promising Investment Opportunities

On Feb. 23, 2021, the AdvisorShares Pure U.S. Cannabis ETF (NYSEARCA: MSOS ) announced it hit $1 billion in assets under management (AUM). Unfortunately, those halcyon days when cannabis stocks ruled have faded away.

The 3 Most Undervalued Cannabis Stocks to Buy Now: August 2023

As we reach mid-August 2023, the attention remains on the top US marijuana stocks, representing the country's thriving cannabis industry. This once-forbidden sector has seen a spectacular metamorphosis in the last decade, with a compound annual growth rate of more than 20%. As legalization spreads across states, the US cannabis business is expected to reach unparalleled heights, with a stunning $41 billion in revenue by 2025.

Top US Marijuana Stocks to Watch in August 2023

Marijuana legalization will solve problems for cannabis companies but it will also make some new ones. Timing the market can be a risky strategy for investors.

Waiting to Buy Marijuana Stocks After Legalization Could Be a Costly Mistake

Innovative Industrial Properties

Constellation Brands

The cannabis realm has piqued investor interest and is well on its way to carving an indelible spot in the investment landscape. As the industry flourishes, the best cannabis stocks to buy have emerged not by chasing mere profits but by committing to sustainable trajectories.

The 3 Best Cannabis Stocks to Buy for August

Earnings season ramped up this week for cannabis multi-state operators (MSOs), with growth within the medical cannabis sector driving positive numbers for companies in the sector. Strong positioning in Florida's growing medical marijuana market in addition to its large retail presence, with 68% of its retail stores located in the state, helped Trulieve Cannabis Corp. (CSE:TRUL) impress.

Cannabis MSOs deliver mixed 2Q: medical boosts Trulieve, Curaleaf faces challenges

Trulieve Cannabis Corp. is weighing options to get reimbursed for up to $400,000 of “personal” expenses by its former chief financial officer, the company said.

Cannabis company Trulieve weighing options after ex-CFO allegedly charged company up to $400,000 for ‘personal expenses'

Trulieve Cannabis Corp. (OTCQX:TCNNF) Q2 2023 Earnings Conference Call August 9, 2023 8:30 AM ET Company Participants Christine Hersey - Vice President, Investor Relations Kim Rivers - Chief Executive Officer Ryan Blust - Interim Chief Financial Officer Steve White - President Conference Call Participants Derek Dley - Canaccord Genuity Matt McGinley - Needham Andrew Partheniou - Stifel Russell Stanley - Beacon Securities Eric DesLauriers - Craig-Hallum Capital Group Scott Fortune - Roth MKM Aaron Grey - Alliance Global Partners Operator Good morning, and welcome to the Trulieve Cannabis Corporation Second Quarter 2023 Financial Results Conference Call. My name is Jason, I will be your conference operator today.

Trulieve Cannabis Corp. (TCNNF) Q2 2023 Earnings Call Transcript

Sold 11.6 million units of branded product through branded retail, up 9% sequentially Maryland dispensary traffic increased 200% in July with adult use launch Industry leading U.S. retail network of 183 dispensaries, up 11% year over year, supported by over 4 million square feet of cultivation and processing capacity as of June 30, 2023 TALLAHASSEE, Fla. , Aug. 9, 2023 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced its results for the quarter ended June 30, 2023.

Trulieve Reports Second Quarter 2023 Results Highlighting Progress on 2023 Plan

Most cannabis investors are looking for top marijuana stocks to buy for future profits. Now with how unpredictable the sector can be any chance to take profits should be done. But the purpose of seeing cannabis stocks as a long-term investment versus short is how the sector has changed. At this point, most of the cannabis sector was good for quick in-and-out trading.

3 Marijuana Stocks To Buy This Week That May See Better Momentum

GrowGeneration Corp

Are you looking to invest in marijuana stocks today? Well, what do you know about the cannabis sector that can help make you some money? The cannabis industry is still relatively young and growing day by day. As more innovation and progress becomes apparent so does the need to find ways to invest. Now for some, it may be better suited to start a cannabis company and build it from the ground up.

3 Marijuana Stocks To Watch In Todays Stock Market 2023

Cannabis stocks are down in 2023 due to plateauing demand, rising production costs, fierce competition and stalled legalization efforts at the federal level. Yet, with shares of many top cannabis producers and retailers down by double-digit percentages, it may be time for investors who are bullish on the sector long term to pounce on some cheap cannabis investments.

Looking for a Bargain? 7 Cannabis Stocks to Buy That Are Down 10% in 2023

New dispensary delivers on brand promise of product quality and variety with convenient locations TALLAHASSEE, Fla. , July 31, 2023 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, announced the relocation of a medical dispensary in Kissimmee, Fla.

News for Trulieve Cannabis Corp. Stock (TCNNF)